RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+36.79%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$724M
AUM Growth
+$724M
(+18%)
Cap. Flow
-$65.6M
Cap. Flow
% of AUM
-9.05%
Top 10 Holdings %
Top 10 Hldgs %
67.17%
Holding
36
New
9
Increased
7
Reduced
9
Closed
3
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$42.5M |
| 2 |
Prothena Corp
PRTA
|
$23.2M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$21.1M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$16.9M |
| 5 |
TherapeuticsMD
TXMD
|
$15.4M |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$123M |
| 2 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$33M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$19.4M |
| 4 |
Omeros
OMER
|
$18.5M |
| 5 |
Arrowhead Research
ARWR
|
$12.7M |
Sector Composition
| 1 | Healthcare | 84.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Arrowhead Research
ARWR
$3.84B
| $5.01M | 0.52% |
879,561
-2,235,194
| -72% | -$12.7M |
|
27
TG Therapeutics
TGTX
$5.03B
| $3.02M | 0.32% |
+600,000
| New | +$3.02M |
|
28
Agios Pharmaceuticals
AGIO
$2.36B
| $1.96M | 0.2% |
+70,000
| New | +$1.96M |
|
|
OCRX
29
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.83M | 0.19% |
215,999
-2,484,001
| -92% | -$76.3K |
|
|
EPZM
30
DELISTED
Epizyme, Inc
EPZM
| $400K | 0.04% |
10,000
-141,000
| -93% | -$5.64M |
|
|
RCPT
31
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-975,000
| Closed | -$19.4M |
|
|
SNMX
32
DELISTED
Senomyx, Inc.
SNMX
| – | – |
-975,610
| Closed | -$2.13M |
|
33
Rockwell Medical
RMTI
$59.6M
| – | – |
0
| – | – |
|
34
Fortress Biotech
FBIO
$87.8M
| – | – |
0
| – | – |
|
35
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-436,145
| Closed | -$7.72M |
|